Allworth Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Allworth Financial’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$247	Hold	1,000	–	–	﹤0.01%	4886
2025 Q4	$420	Hold	1,000	–	–	﹤0.01%	4565
2025 Q3	$674	Hold	1,000	–	–	﹤0.01%	4363
2025 Q2	$542	Hold	1,000	–	–	﹤0.01%	4116
2025 Q1	$815	Hold	1,000	–	–	﹤0.01%	3535
2024 Q4	$1.15K	Hold	1,000	–	–	﹤0.01%	3349
2024 Q3	$867	Hold	1,000	–	–	﹤0.01%	3272
2024 Q2	$398	Sell	1,000 -497	-33%	-$269	﹤0.01%	3431
2024 Q1	$1K	Hold	1,497	–	–	﹤0.01%	3078
2023 Q4	$814	Buy	1,497 +497	+50%	+$229	﹤0.01%	3017
2023 Q3	$600	Hold	1,000	–	–	﹤0.01%	3000
2023 Q2	$1.3K	Hold	1,000	–	–	﹤0.01%	2649
2023 Q1	$1.76K	Hold	1,000	–	–	﹤0.01%	2456
2022 Q4	$3.14K	Hold	1,000	–	–	﹤0.01%	2069
2022 Q3	$5K	Hold	1,000	–	–	﹤0.01%	1893
2022 Q2	$4K	Hold	1,000	–	–	﹤0.01%	1840
2022 Q1	$6K	Hold	1,000	–	–	﹤0.01%	1606
2021 Q4	$8K	Hold	1,000	–	–	﹤0.01%	1476
2021 Q3	$9K	Hold	1,000	–	–	﹤0.01%	1384
2021 Q2	$12K	Sell	1,000 -50	-5%	-$566	﹤0.01%	999
2021 Q1	$13K	Buy	1,050 +50	+5%	+$674	﹤0.01%	915
2020 Q4	$16K	Hold	1,000	–	–	﹤0.01%	723
2020 Q3	$9K	Hold	1,000	–	–	﹤0.01%	744
2020 Q2	$9K	Hold	1,000	–	–	﹤0.01%	755
2020 Q1	$6K	Hold	1,000	–	–	﹤0.01%	838
2019 Q4	$8K	Hold	1,000	–	–	﹤0.01%	691
2019 Q3	$9K	Hold	1,000	–	–	﹤0.01%	605
2019 Q2	$11K	Hold	1,000	–	–	﹤0.01%	568
2019 Q1	$10K	Hold	1,000	–	–	﹤0.01%	577
2018 Q4	$11K	Hold	1,000	–	–	﹤0.01%	508
2018 Q3	$17K	Hold	1,000	–	–	﹤0.01%	461
2018 Q2	$14K	Hold	1,000	–	–	﹤0.01%	466
2018 Q1	$19K	Hold	1,000	–	–	﹤0.01%	385
2017 Q4	$16K	Hold	1,000	–	–	﹤0.01%	408
2017 Q3	$15K	Hold	1,000	–	–	﹤0.01%	411
2017 Q2	$9K	Hold	1,000	–	–	﹤0.01%	492
2017 Q1	$5K	Hold	1,000	–	–	﹤0.01%	540
2016 Q4	$3K	Hold	1,000	–	–	﹤0.01%	549
2016 Q3	$5K	Hold	1,000	–	–	﹤0.01%	508
2016 Q2	$6K	Hold	1,000	–	–	﹤0.01%	439
2016 Q1	$6K	Hold	1,000	–	–	﹤0.01%	432
2015 Q4	$9K	Hold	1,000	–	–	﹤0.01%	388
2015 Q3	$6K	Hold	1,000	–	–	﹤0.01%	434
2015 Q2	$11K	Hold	1,000	–	–	﹤0.01%	378
2015 Q1	$16K	Buy	+1,000	New	+$15.5K	0.01%	338

Other funds holding SGMO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Allworth Financial's SGMO Position: Q1 2026 in Review

Allworth Financial held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 1,000 shares worth $247. The position accounts for ﹤0.01% of the portfolio, ranked #4886.

Allworth Financial first reported a position in SGMO in Q1 2015 and has held it in 45 quarters since. The position peaked at $19K in Q1 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

Allworth Financial held 1,000 shares of SANGAMO THERAPEUTICS INC worth $247 as of Q1 2026.
Allworth Financial left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4886 holding.
Allworth Financial first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and has held it in 45 quarters since.
Allworth Financial's SANGAMO THERAPEUTICS INC position peaked at $19K in Q1 2018.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.